...
首页> 外文期刊>Toxicon: An International Journal Devoted to the Exchange of Knowledge on the Poisons Derived from Animals, Plants and Microorganisms >Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a naive phage display library: preliminary findings for antivenom development
【24h】

Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a naive phage display library: preliminary findings for antivenom development

机译:从幼稚噬菌体展示文库中分离,表征和五聚化α-钴毒素特异性单域抗体:抗蛇毒血清发育的初步发现

获取原文
获取原文并翻译 | 示例
           

摘要

Conventional antivenoms to snakebite generated from the serum of immunized animals, often elicit adverse reactions and have mismatched pharmacokinetic profiles with their target toxins due to antibody/toxin size discrepancies which results in poor neutralization. Furthermore, animal immunization protocols are often lengthy and have batch to batch variability. Recombinant V(H)H-based antivenoms may help overcome these problems. Three V(H)H fragments with specificity to alpha-cobrotoxin, a snake neurotoxin from Naja kaouthia venom, were isolated from a naive llama V(H)H phage-display library. Alpha-cobrotoxin-binding specificity was determined using a phage-displayed V(H)H ELISA format. Sequence analysis shows two of the three clones differ by only two amino acid substitutions, while the third is unique. Surface plasmon resonance analysis determined the K(D) values of the interactions to be 2, 3 and 3 microM. These affinities are too low for alpha-cobrotoxin detection in a standard ELISA format, or for practical use as therapeutic agents. However, improved functional affinity was obtained via antibody pentamerization and alpha-cobrotoxin detection was possible using a pentabody-based ELISA. Development of antivenoms composed of a mixture of antibody fragments, such as V(H)Hs and V(H)H multimers, may help match the pharmacokinetic profiles of complex venoms, improving antivenom biodistribution, and toxin neutralization while reducing adverse effects in humans.
机译:从免疫动物的血清中产生的蛇咬伤的常规抗癫痫药通常会引起不良反应,并且由于抗体/毒素大小差异而导致药代动力学特征与其目标毒素不匹配,导致中和性差。此外,动物免疫方案通常很长,并且具有批次间的可变性。重组基于V(H)H的抗氧化剂可以帮助克服这些问题。从幼稚的美洲驼V(H)H噬菌体展示文库中分离出了三个对α-cobrotoxin特异性的V(H)H片段,α-cobrotoxin是来自Naja kaouthia毒液的蛇神经毒素。使用噬菌体展示的V(H)H ELISA格式确定α-cobrotoxin结合特异性。序列分析显示,三个克隆中的两个仅相差两个氨基酸,而第三个是唯一的。表面等离子体共振分析确定相互作用的K(D)值为2、3和3 microM。这些亲和力太低,无法以标准ELISA格式检测α-cobrotoxin,也无法实际用作治疗剂。然而,通过抗体五聚化获得了改善的功能亲和力,并且使用基于五抗体的ELISA可以检测α-cobrotoxin。由抗体片段(例如V(H)Hs和V(H)H多聚体)的混合物组成的抗蛇毒素的开发,可以帮助匹配复杂毒液的药代动力学特征,改善抗蛇毒素的生物分布和毒素中和,同时减少对人体的不良影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号